BA
The Boeing Company
BA has a slight edge over MSM overall, supported by stronger valuation and stronger fundamentals.
MSM
MSC Industrial Direct Co., Inc.
MSM has lower modeled downside risk, despite its lower overall score.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
MSM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Healthy |
MSM's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over MSM in the historical PE scenario, which offers more potential upside but is not a forecast.
MSM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $55.77 | -53% |
| Fair | 17x | $67.64 | -43% |
| Forward | 21x | $119 | — |
| Expensive | 25x | $98.52 | -18% |
| Current | 30x | $119 | — |
Historical ranges are pointers, not guarantees.
MSM's PE is in its expensive range at 30x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
MSM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MSM, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over MSM on earnings, with more consistent year-over-year improvement.
MSM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.66 | +42% |
| Q3 2026 | $3.98 | +11% |
| Q2 2026 | $4.15 | +17% |
| Q1 2026 | $3.73 | -1.6% |
| Q4 2025 | $3.67 | -12% |
| Q3 2025 | $3.57 | -22% |
| Q2 2025 | $3.54 | -31% |
| Q1 2025 | $3.79 | -32% |
| Q4 2024 | $4.19 | -29% |
MSM's earnings per share have fallen from their peak: $3.98 over the past year, against $6.49 in early 2023.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over MSM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
MSM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +10% |
| Q2 2026 | $1B | +7.8% |
| Q1 2026 | $917.8M | +2.9% |
| Q4 2025 | $965.7M | +4% |
| Q3 2025 | $978.2M | +2.7% |
| Q2 2025 | $971.1M | -0.8% |
| Q1 2025 | $891.7M | -4.7% |
| Q4 2024 | $928.5M | -2.7% |
MSM's revenue has grown year over year for five quarters in a row: $1.1B last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.8% | -1.9 points |
| Q2 2026 | 10% | +1.7 points |
| Q1 2026 | 7.1% | +0.1 points |
| Q4 2025 | 7.9% | +0.1 points |
| Q3 2025 | 8.6% | -0.9 points |
| Q2 2025 | 8.5% | -2.4 points |
| Q1 2025 | 7% | -2.8 points |
| Q4 2024 | 7.8% | -2.9 points |
MSM has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over MSM on cash flow, with more consistent year-over-year improvement.
MSM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $63.8M | +8.9% |
| Q2 2026 | $80.9M | +6.5% |
| Q1 2026 | $73.1M | +196% |
| Q4 2025 | $7.4M | -91% |
| Q3 2025 | $58.5M | -28% |
| Q2 2025 | $76M | -33% |
| Q1 2025 | $24.7M | -54% |
| Q4 2024 | $81.7M | +30% |
MSM still generates free cash flow, though less than at its 2023 peak: $225M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
MSM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.2% | +96K shares |
| 3 years | -0.4% | -220K shares |
| 5 years | -0.2% | -103K shares |
| Available history | +1% | +546K shares |
MSM has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $73,000 |
| Q2 2026 | $171,000 |
| Q1 2026 | $764,000 |
| Q4 2025 | $13M |
| Q3 2025 | $179,000 |
| Q2 2025 | $8.6M |
| Q1 2025 | $12.5M |
| Q4 2024 | $18.1M |
MSM spent $14M buying back its own shares over the past year, down 64% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
MSM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.0x | Very low |
| Q2 2026 | 1.0x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.0x | Healthy |
MSM has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
MSM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.3 | Neutral |
| Stochastic | 31.0 | Neutral |
MSM's weekly RSI is 52 (neutral) and its Stochastic is 31 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over MSM on valuation relative to its sector.
MSM PE vs Industrials Sector
| Metric | MSM | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 24x | 25% above |
| PE % | 97 | 58 | 39 pts above |
MSM is trading at 30x earnings, a 25% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
MSM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $122.4 | 2.4% below |
| 20 week MA | $122.4 | 2.4% below |
| 50 week MA | $106.6 | 12% above |
| 100 week MA | $95.0 | 26% above |
| 200 week MA | $93.0 | 28% above |
MSM has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
MSM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $79.0 | $85.9 | +8.7% |
| 2021 | $85.9 | $83.9 | -2.3% |
| 2022 | $83.9 | $83.3 | -0.8% |
| 2023 | $83.3 | $101.3 | +22% |
| 2024 | $101.3 | $74.8 | -26% |
| 2025 | $74.8 | $87.4 | +17% |
| 2026 YTD | $87.4 | $119.4 | +37% |
MSM has the edge over BA on returns for 2026, with the stronger performance.